Literature DB >> 33578090

Self-navigated versus navigator-gated 3D MRI sequence for non-enhanced aortic root measurement in transcatheter aortic valve implantation.

Mathias Pamminger1, Christof Kranewitter1, Christian Kremser1, Martin Reindl2, Sebastian J Reinstadler2, Benjamin Henninger1, Gert Reiter3, Davide Piccini4, Christina Tiller2, Magdalena Holzknecht2, Ivan Lechner2, Axel Bauer2, Gert Klug2, Bernhard Metzler2, Agnes Mayr5.   

Abstract

OBJECTIVES: To prospectively compare image-quality, reliability and graft sizing of a prototype self-navigated and a navigator-gated non-contrast three dimensional (3D) whole-heart magnetic-resonance-angiography (MRA) sequence with computed-tomography-angiography (CTA) for planning transcatheter-aortic-valve-implantation (TAVI).
METHODS: Self- and navigator-gated 1.5 T MRA were performed in 27 patients (aged 83 ± 5 years, 41 % male) for aortic root sizing and coronary ostia height measurements; 15 (56 %) patients underwent additional CTA. Subjective-image quality was graded on a 4-point Likert scale, objective MRA image-quality was assessed by signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR). Continuous MRA and CTA measurements were analyzed with regression and Bland-Altman analysis, valve sizing by kappa statistics.
RESULTS: Median image-quality as rated by two observers was 1.5 [interquartile range (IQR) 1-3] for self-navigated MRA and 1 [IQR 1-2] for navigator-gated MRA (p = 0.059). SNR and CNR were comparable between MRA sequences (p = 0.471 and 0.445, respectively). Acquisition time was shorter for self-navigated MRA compared to navigator-gated MRA (5.5 ± 1 min vs, 6.5 ± 2 min, p = 0.029). Inter-observer correlation of aortic root measurements was high to very high for both self- and navigator-gated MRA (r = 0.75 to 0.94 and r = 0.85 to 0.96, respectively, all p < 0.0001). Theoretical prosthetic valve sizing of self-navigated MRA and CTA was equivalent (κ = 1). However, in four patients (15 %) one coronary ostium each (right coronary artery 3, left main artery 1) was not clearly definable on self-navigated MRA.
CONCLUSION: Self-navigated MRA enables aortic annulus TAVI measurements without significant difference to navigator-gated MRA at shortened acquisition time. Prosthesis sizing by self-navigated MRA measurements is equivalent to navigator-gated MRA and CTA-based choice.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Computed tomography angiography (CTA); Magnetic resonance angiography (MRA); Transcatheter aortic valve replacement (TAVR)

Mesh:

Year:  2021        PMID: 33578090     DOI: 10.1016/j.ejrad.2021.109573

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  4 in total

Review 1.  Preoperative TAVR Planning: How to Do It.

Authors:  Rodrigo Petersen Saadi; Ana Paula Tagliari; Eduardo Keller Saadi; Marcelo Haertel Miglioranza; Carisi Anne Polanczyck
Journal:  J Clin Med       Date:  2022-05-05       Impact factor: 4.964

2.  Coronary Artery Magnetic Resonance Angiography Combined with Computed Tomography Angiography in Diagnosis of Coronary Heart Disease by Reconstruction Algorithm.

Authors:  Yun Ling; Jiapei Qiu; Jun Liu
Journal:  Contrast Media Mol Imaging       Date:  2022-03-23       Impact factor: 3.009

3.  Efficient non-contrast enhanced 3D Cartesian cardiovascular magnetic resonance angiography of the thoracic aorta in 3 min.

Authors:  Anastasia Fotaki; Camila Munoz; Yaso Emanuel; Alina Hua; Filippo Bosio; Karl P Kunze; Radhouene Neji; Pier Giorgio Masci; René M Botnar; Claudia Prieto
Journal:  J Cardiovasc Magn Reson       Date:  2022-01-10       Impact factor: 5.364

4.  Cardiac magnetic resonance imaging versus computed tomography to guide transcatheter aortic valve replacement: study protocol for a randomized trial (TAVR-CMR).

Authors:  Gert Klug; Sebastian Reinstadler; Felix Troger; Magdalena Holzknecht; Martin Reindl; Christina Tiller; Ivan Lechner; Priscilla Fink; Mathias Pamminger; Christian Kremser; Hanno Ulmer; Axel Bauer; Bernhard Metzler; Agnes Mayr
Journal:  Trials       Date:  2022-09-02       Impact factor: 2.728

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.